Immune Cell Therapy Market Size BURLINGAME, CA, UNITED STATES, June 19, 2025 /EINPresswire / --The latest research study released by C ...

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

It’s back to the drawing board for bluebird bio and its discussions with NICE, which has rejected its beta thalassaemia gene therapy Zynteglo ... came from a small sample of patients and is ...

BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I ...

When I started dating again after my first big breakup, I thought the key to finding love was being as palatable as possible.

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

The rising Chinese auteur’s genre-bending drama, unveiled at the Shanghai Film Festival, uses a virtual reality boxing ...

Small transactions may not always make the headlines, but they’re the lifeblood of pharma innovation. So says Juergen ...

GeneDx Holdings Corp. leverages genomics leadership with robust growth, despite recent stock challenges. Click for more on ...